naproxen sodium

Generic: naproxen sodium

Labeler: sciegen pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name naproxen sodium
Generic Name naproxen sodium
Labeler sciegen pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

naproxen sodium 275 mg/1

Manufacturer
ScieGen Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 50228-432
Product ID 50228-432_42789c45-a1bd-b3f9-e063-6294a90a8067
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA212199
Listing Expiration 2026-12-31
Marketing Start 2019-10-30

Pharmacologic Class

Classes
anti-inflammatory agents non-steroidal [cs] cyclooxygenase inhibitors [moa] nonsteroidal anti-inflammatory drug [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50228432
Hyphenated Format 50228-432

Supplemental Identifiers

RxCUI
849398 849431
UPC
0350228432306 0350228432016 0350228433303 0350228433013
UNII
9TN87S3A3C

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name naproxen sodium (source: ndc)
Generic Name naproxen sodium (source: ndc)
Application Number ANDA212199 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 275 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (50228-432-01)
  • 500 TABLET in 1 BOTTLE (50228-432-05)
  • 1000 TABLET in 1 BOTTLE (50228-432-10)
  • 30 TABLET in 1 BOTTLE (50228-432-30)
source: ndc

Packages (4)

50228-432-01 100 TABLET in 1 BOTTLE (50228-432-01) 50228-432-05 500 TABLET in 1 BOTTLE (50228-432-05) 50228-432-10 1000 TABLET in 1 BOTTLE (50228-432-10) 50228-432-30 30 TABLET in 1 BOTTLE (50228-432-30)

Ingredients (1)

naproxen sodium (275 mg/1)

Linked Drug Pages (1)

Naproxen Sodium ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "42789c45-a1bd-b3f9-e063-6294a90a8067", "openfda": {"upc": ["0350228432306", "0350228432016", "0350228433303", "0350228433013"], "unii": ["9TN87S3A3C"], "rxcui": ["849398", "849431"], "spl_set_id": ["79f48c92-783d-40f2-9865-89958a9f9de6"], "manufacturer_name": ["ScieGen Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (50228-432-01)", "package_ndc": "50228-432-01", "marketing_start_date": "20191030"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (50228-432-05)", "package_ndc": "50228-432-05", "marketing_start_date": "20191030"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (50228-432-10)", "package_ndc": "50228-432-10", "marketing_start_date": "20191030"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (50228-432-30)", "package_ndc": "50228-432-30", "marketing_start_date": "20191030"}], "brand_name": "Naproxen Sodium", "product_id": "50228-432_42789c45-a1bd-b3f9-e063-6294a90a8067", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "50228-432", "generic_name": "Naproxen Sodium", "labeler_name": "ScieGen Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Naproxen Sodium", "active_ingredients": [{"name": "NAPROXEN SODIUM", "strength": "275 mg/1"}], "application_number": "ANDA212199", "marketing_category": "ANDA", "marketing_start_date": "20191030", "listing_expiration_date": "20261231"}